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Respiratory complex I from the aerobic yeast Yarrowia lipolytica
contains 14 central subunits intimately linked with energy conserva-
tion and at least 28 accessory subunits [1]. The accessory NUMM
subunit is a member of the zf — CHCC superfamily (PF 10276; Pfam
database) and carries a zinc ﬁnger motif: CX8HX14CX2C which is
highly conserved in orthologous subunits found from alpha-
proteobacteria to humans [2].
We have mutated all conserved residues of the putative zinc
binding motif in the NUMM subunit from Y. lipolytica and investigat-
ed the impact on assembly and activity of complex I. Deletion of the
subunit severely affected complex I assembly. Complementation with
the subunit carrying a mutation of a cysteine previously reported to
play a role in the pathogenesis of fatal neonatal lactic acidemia [3]
rescued assembly but diminished ubiquinone reductase activity.
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We discovered a very potent and speciﬁc inhibitor (NADH-OH)
of mitochondrial complex I (NADH:ubiquinone reductase) [1]. The
inhibitor is spontaneously formed during aerobic incubation of
the reduced dinucleotide under alkaline conditions or in anaero-
biosis in the presence of H2O2, and Fe+2 or Cu+2. The latter suggests
that the mechanism of NADH-OH formation includes modiﬁcation of
NADH with hydroxyl radical (OH·). The molecular mass of NADH-OH
estimated by ESI-MS (696 Daltons) and preliminary 1H NMR data
indicate that the inhibitor is derived from attachment of two oxygen
atoms one to the adenine residue and the other to the nicotinamide
residue of the inhibitor. NADH-OH is competitive with respect to
NADH with a Ki of about 10−8 M. The inhibitor efﬁciently inhibits
NADH-oxidase, NADH-artiﬁcial acceptor reductase, and NADH-
quinone reductase reactions catalyzed by submitochondrial particles,
as well as the reactions catalyzed by either isolated complex I or the
three subunit ﬂavoprotein fragment of complex. The inhibitor also
strongly suppressed a succinate-supported superoxide generation by
complex I [2].
The structural similarity of NADH-OH and NADH, the high potency
and speciﬁcity of the inhibitor with respect to complex I and its ability
to suppress ROS formation [2] raise the exciting possibility that it is a
natural derivative of NADH that can modulate activity of complex I in
normal conditions and under periods of oxidative stress. It may be
possible that NADH-OH could be produced in mitochondria by
enzymatic hydroxylation of the nicotinamide ring of NADH under
certain metabolic conditions. If indeed the inhibitor can be produced
in cells this would provide important insights for understanding the
mechanism of complex I regulation in vivo.
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The work presented deals with the use of Fourier Transform
Infrared spectroscopy (FTIR) applied to biomolecules, especially to the
ﬁrst enzyme of the respiratory chain, the NADH:ubquinone oxidore-
ductase, also called Complex I. Complex I couples the oxidation of
NADH into NAD+ to the reduction of ubiquinone into ubiquinol. The
electrons gained from the oxidation of NADH are transferred to the
quinone through one FMN and up to 9 Fe/S clusters. The process is
coupled to the translocation of 4 protons across the membrane by a
mechanism involving long-range conformational movements. This
process is not yet fully understood, although recent X-ray structure
[1] revealed that it seems to function in a piston-like manner.
Complex I is a primary target for herbicides and is thought to be
involved in various diseases, e.g. Parkinson disease or Alzheimer's
disease, and in aging [2]. To study its role in these processes and to
gain new insights in the structure–function relationship of the
protein, a method to create a molecular probe is proposed here. It
involves FT-IR absorption spectroscopy in combination with other
techniques, as electrochemistry and perfusion [3]. Particular attention
is given to Surface Enhanced IR Absorption Spectroscopy (SEIRAS) [4],
a variation of Attenuated Total Reﬂection (ATR) IR Spectroscopy.
SEIRAS uses a thin gold layer deposited on top of a Si crystal to
enhance IR absorption. This gold layer provides a convenient way to
attach molecules on its surface and can also be used as a working
electrode for electrochemical experiments.
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Mitochondrial diseases are a plethora of oxidative phosphoryla-
tion (OXPHOS) related disorders, which have an estimated preva-
lence of, 1:5000 in children and 1:10,000 in adults. Mitochondrial
disorders in adulthood generally are caused by mutations in the
mitochondrial DNA (mtDNA), whereas pediatric disorders are often
associated with nuclear DNA (nDNA) mutations. The inheritance of
these disorders, could be maternal or mendelian depending on the
origin, if the mutation is in the mtDNA or nDNA respectively [1,2].
Most mitochondrial functions, including aerobic ATP production,
require an inside negative potential (Δψ) across the mitochondria
inner membrane (MIM). This Δψ is sustained by the action of the
electron transport chain (ETC), which together with the ATP-
synthesizing F0F1-ATPase, constitutes the oxidative phosphorylation
(OXPHOS) system. The ETC consists of four complexes (CI–CIV) of
which CI is the largest and least well understood. Importantly,
inherited mutations in nDNA-encoded CI subunits are the most
frequent cause of OXPHOS deﬁciency in humans. In this project we
use a knockout animal model with severe nDNA CI dysfunction,
displaying behavioral and pathophysiological changes leading to
disease symptoms and a lethal phenotype [3].
We analyzed the biochemical and metabolic consequences of this
dysfunction in tissues with high energy demand at the level of
substrate oxidation, ATP production and biochemical activities of the
respiratory chain complexes. Our ﬁndings indicate, that there is tissue
speciﬁc adaptation seen in the skeletal muscle and the heart, however
we do not observe the same adaptation in the brain. This leads us to
conclude that the brain is the most affected tissue due to CI
deﬁciency. We believe that our data will help in creating rational
mitigative strategies, which will be targeting the brain to treat this
fatal phenotype.
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Respiratory complex I is present in the three domains of life and
plays a central role in energy transduction. It catalyzes the oxidation
of NADH and reduction of quinones, coupled to cation translocation
across the membrane, thereby establishing an electrochemical
potential. It is a large enzyme composed by a peripheral and a
membrane part in an L-shaped assembly. This enzyme is an example
of the modular structure observed in several energy transducing
enzymes. The complex I from prokaryotes may be viewed as a
combination of 14 modules most of which identiﬁed in other
complexes, such as type 4 membrane-bound [NiFe] hydrogenases
and some subunits of Mrp Na+/H+ antiporters.
In this work we put forward a thorough taxonomic proﬁle of
prokaryotic type 4 membrane-bound [NiFe] hydrogenases, complex I
and complex I-like enzymes which have at least four common
subunits that we dominated as the universal adaptor (NuoH, L, B
and D). In addition we investigated the different gene clustering
organization of such complexes. We showed the presence of
complexes related to hydrogenases, named before Ehr (Energy-
converting hydrogenases related complexes), but which do not
contain the binding site of the catalytic centre (NiFe). These
complexes are a missing link between complex I and type 4
membrane-bound [NiFe]-hydrogenases. Based on our observation
we discuss the evolutionary, functional and mechanistic implications
of a different perspective for the relation between complex I and
related enzymes.
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NADH:quinone oxidoreductase (complex I) is the ﬁrst enzyme of
the respiratory chain and the entry point for NADH, a high energy
electron carrier. The mammalian complex consists of 45 subunits
with a combined mass of 980 kDa, whilst its highly conserved
bacterial homologue contains approximately 14 subunits with a mass
of 550 kDa. The prokaryotic enzyme still maintains the core
bioenergetics function and therefore represents a minimal model for
the mammalian enzyme. Complex I catalyses the reduction of
quinone to quinol by transferring electrons from NADH, via a series
of non-covalently bound prosthetic groups. The process of electron
transfer is coupled to proton translocation across the membrane
which establishes a proton motive force; the mechanism, however,
remains largely unknown.
Quinone is proposed to bind at the interface between the
hydrophilic and membrane domain. The present structure of complex
I from Thermus thermophilus [1] suggests that once quinone is bound
to the membrane domain, it has to move into the hydrophilic domain
by up to 20 Å, to be within close proximity of the N2 iron–sulphur
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